NASDAQ:TNDM Tandem Diabetes Care (TNDM) Stock Price, News & Analysis $16.65 +0.20 (+1.22%) Closing price 10/13/2026 04:00 PM EasternExtended Trading$16.67 +0.02 (+0.12%) As of 04:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Tandem Diabetes Care Stock (NASDAQ:TNDM) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Tandem Diabetes Care alerts:Sign Up Key Stats Today's Range$15.72▼$16.8050-Day Range$15.22▼$23.7352-Week Range$12.26▼$29.65Volume1.71 million shsAverage Volume2.34 million shsMarket Capitalization$1.16 billionP/E RatioN/ADividend YieldN/APrice Target$27.08Consensus RatingHold Company Overview Tandem Diabetes Care, Inc. is a medical device company focused on developing and commercializing advanced insulin delivery systems for people with diabetes. The company’s products are designed to work with continuous glucose monitoring (CGM) systems and digital health tools to help automate and personalize insulin therapy. Tandem’s product portfolio includes the t:slim X2 insulin pump, which features a rechargeable design and software that supports automated insulin delivery. The company also offers the t:slim X2 pump with Control-IQ technology, an algorithm designed to adjust insulin delivery based on CGM readings, and the compact Tandem Mobi pump. Its t:connect diabetes management platform supports data collection, remote monitoring and therapy management for patients and healthcare providers. Founded in 2006 and headquartered in San Diego, California, Tandem Diabetes Care serves customers in the United States and international markets through direct commercial operations and distribution partners. The company’s products are intended for use by people with insulin-dependent diabetes, including individuals with type 1 diabetes. John Sheridan serves as the company’s president and chief executive officer.AI Generated. May Contain Errors. Read More Tandem Diabetes Care Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks50th Percentile Overall ScoreTNDM MarketRank™: 2.51187961985 of 5 starsTandem Diabetes Care scored higher than 50% of companies evaluated by MarketBeat, and ranked 547th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingHold Consensus RatingTandem Diabetes Care has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 1 strong buy rating, 9 buy ratings, 12 hold ratings, and 1 sell rating.Upside PotentialTandem Diabetes Care has a consensus price target of $27.08, representing about 62.6% upside from its current price of $16.65.Amount of Analyst CoverageTandem Diabetes Care has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Tandem Diabetes Care's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Tandem Diabetes Care are expected to grow in the coming year, from ($0.66) to $0.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tandem Diabetes Care is -17.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tandem Diabetes Care is -17.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioTandem Diabetes Care has a P/B Ratio of 7.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Tandem Diabetes Care's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted19.63% of the float of Tandem Diabetes Care has been sold short.Short Interest Ratio / Days to CoverTandem Diabetes Care has a short interest ratio ("days to cover") of 5.25.Change versus previous monthShort interest in Tandem Diabetes Care has recently increased by 7.17%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTandem Diabetes Care does not currently pay a dividend.Dividend GrowthTandem Diabetes Care does not have a long track record of dividend growth. News and Social Media3.3 / 5News Sentiment1.24 News SentimentTandem Diabetes Care has a news sentiment score of 1.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Tandem Diabetes Care this week, compared to 5 articles on an average week.Search InterestOnly 1 people have searched for TNDM on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Tandem Diabetes Care insiders have not sold or bought any company stock.Percentage Held by Insiders2.10% of the stock of Tandem Diabetes Care is held by insiders.Percentage Held by InstitutionsTandem Diabetes Care has minimal institutional ownership at this time.Read more about Tandem Diabetes Care's insider trading history. Receive TNDM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tandem Diabetes Care and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TNDM Stock News HeadlinesTandem Diabetes Care, Inc. (NASDAQ:TNDM) Stock Now Rated "Hold" by Wall Street BrokeragesOctober 13 at 2:28 AM | americanbankingnews.comBarclays Keeps Their Hold Rating on Tandem Diabetes Care (TNDM)October 12 at 2:48 PM | theglobeandmail.comA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe calls it The 10-Minute Guide to Start Trading Options Today, built to help you open your first options trade with less capital than buying shares outright.October 14 at 1:00 AM | True Market Insiders (Ad)Tandem Diabetes Care (NASDAQ:TNDM) Stock Rating Upgraded by BarclaysOctober 8, 2026 | americanbankingnews.comBarclays initiates coverage of Tandem Diabetes Care at equal-weightOctober 7, 2026 | msn.comTandem Diabetes Care (TNDM) Receives a Buy from RBC CapitalOctober 5, 2026 | theglobeandmail.comTandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026October 1, 2026 | finance.yahoo.comTandem Diabetes Care (TNDM) Is Up 7.2% After International Launch Of Mobi Insulin Pump SystemOctober 1, 2026 | finance.yahoo.comSee More Headlines TNDM Stock Analysis - Frequently Asked Questions How have TNDM shares performed this year? Tandem Diabetes Care's stock was trading at $21.98 at the beginning of the year. Since then, TNDM shares have decreased by 24.2% and is now trading at $16.65. How were Tandem Diabetes Care's earnings last quarter? Tandem Diabetes Care, Inc. (NASDAQ:TNDM) announced its quarterly earnings data on Thursday, August, 6th. The medical device company reported ($0.31) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.32) by $0.01. The business's revenue for the quarter was up 5.8% on a year-over-year basis. Read the conference call transcript. When did Tandem Diabetes Care's stock split? Shares of Tandem Diabetes Care reverse split before market open on Tuesday, October 10th 2017.The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did Tandem Diabetes Care IPO? Tandem Diabetes Care (TNDM) raised $112 million in an initial public offering (IPO) on Thursday, November 14th 2013. The company issued 8,000,000 shares at $13.00-$15.00 per share. How do I buy shares of Tandem Diabetes Care? Shares of TNDM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Tandem Diabetes Care own? Based on aggregate information from My MarketBeat watchlists, some other companies that Tandem Diabetes Care investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Micron Technology (MU), Block (XYZ), Roku (ROKU) and DexCom (DXCM). Company Calendar Last Earnings8/06/2026Today10/14/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (3w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 3 weeks, TNDM's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:TNDM CIK1438133 Webwww.tandemdiabetes.com Phone(858) 366-6900FaxN/AEmployees2,500Year Founded2006Price Target and Rating Average Price Target for Tandem Diabetes Care$27.08 High Price Target$50.00 Low Price Target$15.50 Potential Upside/Downside+62.6%Consensus RatingHold Rating Score (0-4)2.43 Research Coverage23 Analysts Profitability EPS (Trailing Twelve Months)($0.93) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$204.71 million Net Margins-6.08% Pretax Margin-5.86% Return on Equity-45.97% Return on Assets-6.23% Debt Debt-to-Equity Ratio4.62 Current Ratio3.18 Quick Ratio2.65 Sales & Book Value Annual Sales$1.01 billion Price / Sales1.14 Cash FlowN/A Price / Cash FlowN/A Book Value$2.29 per share Price / Book7.27Miscellaneous Outstanding Shares69,580,000Free Float68,118,000Market Cap$1.16 billion OptionableOptionable Beta1.66 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:TNDM) was last updated on 10/13/2026 by MarketBeat.com Staff. From Our PartnersWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredThis AI fund posted a 34 percent annualized payout last monthOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...Weiss Ratings | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tandem Diabetes Care, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tandem Diabetes Care With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
